Depressed host immunity in a case of metachronous primary uterine papillary serous carcinoma and non-Hodgkin's lymphoma

International Journal of Gynecological Cancer

Volumn 14, Issue 5, 2004, Pages 1030-1032

  Chang, W C ^a   Sheu, Bor Ching ^a   Chen, R C ^a   Chow, S N ^a   Huang, S C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Metachronous primary malignant tumors; Non Hodgkin's lymphoma; Uterine papillary serous carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNITY; MEDICAL LITERATURE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PAPILLARY CARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; UTERINE PAPILLARY SEROUS CARCINOMA; UTERUS CARCINOMA;

CARCINOMA, PAPILLARY; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOCOMPROMISED HOST; KILLER CELLS, NATURAL; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; T-LYMPHOCYTES; UTERINE NEOPLASMS;

EID: 4544295681     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891X.2004.014547.x     Document Type: Article

References (7)

1. Engin K. Cancers in multiple primary sites. Int Surg 1994;79:33-7.
2. Lee TK, Richard TM, Modesto S, Richard BM. Multiple primary malignant tumors (MPMT): study of 68 autopsy cases (1963-1980). J Am Geriatr Soc 1982;30:744-53.
3. Gallion HH, Nagel JR, Donalson ES, Powel DE. Endometrial cancer following radiation therapy for cervical cancer. Gynecol Oncol 1987;27:76-83.
4. Parkash V, Carcangiu ML. Uterine papillary serous carcinoma after radiation therapy for carcinoma of cervix. Cancer 1992;69:496-501.
5. Dong C, Hemminki K. Second primary neoplasm among 53,139 hematolympho-proliferative malignancies patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 2001;85:997-1005.
6. Sheu BC, Hsu SM, Ho HN, Lin RH, Huang SC. Tumor immunology - When a cancer cell meets the immune cells. J Formos Med Assoc 1999;98:730-5.
7. Sheu BC, Hsu SM, Ho HN, Lin RH, Tong PL, Huang SC. Reversed CD4/CD8 ratio of tumor infiltrating lymphocytes correlate with disease progression in human cervical cancer. Cancer 1999;86:1537-43.